10 likes | 33 Views
According to a recent report by Morgan Stanley, as many as nine drugs in the biologics category have either gone off patent or will do so by 2025. Their total revenue was $62 billion (around INR 4.3 lakh crore) in 2018. <br><br>Follow the link for Registration: https://www.bharatbook.com/events/14th-biosimilars-congregation-2019/11
E N D
14 th BiosimilarsCongregation “Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars” 2019 12December , 2019 8:30AMto5:00PM KohinoorContinentalHotel, AndheriKurla Road, Andheri ( E ), Mumbai400059 - India www.bharatbook.cominfo@bharatbook.com +912227810772, 73